<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02369302</url>
  </required_header>
  <id_info>
    <org_study_id>DW_DWJ1367001</org_study_id>
    <nct_id>NCT02369302</nct_id>
  </id_info>
  <brief_title>Pharmacokinetics and Drug Interaction Study Between DWC20141 and DWC20142 in Healthy Male Volunteers</brief_title>
  <official_title>An Open-label, Randomized, 6-Sequence, 3-Period Crossover Study to Evaluate a Drug Interaction Between DWC20141 and DWC20142 in Healthy Adult Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Daewoong Pharmaceutical Co. LTD.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Daewoong Pharmaceutical Co. LTD.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the pharmacokinetics profile and drug-drug
      interaction between DWC20141 and DWC20142 in healthy adult subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cmax,ss</measure>
    <time_frame>Multiple blood sample will be collected for 24 hours after last dosing in each of the periods</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>AUCtau</measure>
    <time_frame>Multiple blood sample will be collected for 24 hours after last dosing in each of the periods</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cmin,ss</measure>
    <time_frame>Multiple blood sample will be collected for 24 hours after last dosing in each of the periods</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tmax</measure>
    <time_frame>Multiple blood sample will be collected for 24 hours after last dosing in each of the periods</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>t1/2</measure>
    <time_frame>Multiple blood sample will be collected for 24 hours after last dosing in each of the periods</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic Ratio</measure>
    <time_frame>Multiple blood sample will be collected for 24 hours after last dosing in each of the periods</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>DWC20141</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>multiple dose of DWC20141</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DWC20142</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>multiple dose of DWC20142</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DWC20141+DWC20142</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>multiple dose of DWC20141 and DWC20142</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DWC20141</intervention_name>
    <description>Tablet</description>
    <arm_group_label>DWC20141</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DWC20142</intervention_name>
    <description>Tablet</description>
    <arm_group_label>DWC20142</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DWC20141, DWC20142</intervention_name>
    <description>Tablet</description>
    <arm_group_label>DWC20141+DWC20142</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Healthy adult male volunteers aged 19 to 45 years

          2. A sybject who has judged to be healthy by the investigator to participate in this
             study based on screening result

          3. A subject who provided written informed consent to participate in this study and
             cooperative with regared to compliance with study related constraints

        Exclusion Criteria:

          1. A subject with sign or symptoms or previously diagnosed disease of liver, digestive
             system, cardiovascular, kidney, respiratory, endocrinology, neurology, immune system,
             hematology, and psychology function or other significant disease and history.

          2. A subject who shows the following result in clinical laboratory test

               -  AST, ALT &gt; 1.25 times of the upper limit of normal range

               -  PR ≥ 210 msec

               -  QRS ≥ 120 msec

               -  QT ≥ 500 msec

               -  QTcF ≥ 500 msec

          3. Subject who has taken other clinical medication from another clinical trial within
             3-months period prior to the first administration of the study medication.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eun-Young Kim, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>BUSAN PAIK HOSPITAL</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Inje University College of Medicine Busan Paik Hospital</name>
      <address>
        <city>Busan</city>
        <state>Busanjin-gu</state>
        <zip>614-735</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 17, 2015</study_first_submitted>
  <study_first_submitted_qc>February 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2015</study_first_posted>
  <last_update_submitted>February 27, 2016</last_update_submitted>
  <last_update_submitted_qc>February 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

